Quay Pharma is an independent, privately owned contract development manufacturing organisation (CDMO). Since 2002 we have proudly delivered over 250 successful projects and exercised continued improvement whilst remaining true to our core values.
Our use of proven manufacturing technologies provides a low economic risk and fast entry in to first in human trials, and its elevated scale-up to future clinical phases.
We have knowledge and expertise in the formulation and development of a wide range of product formats and dosage forms for modified and targeted release within the body.
We are licensed for the clinical and commercial manufacturing of new chemical entities, biologicals and live biotherareutics in a non-sterile environment.
Our core strength is our people, we invest in the best, only experts with strong scientific backgrounds underpins the service we deliver.